Effect of once-per-day tacrolimus versus twice-per-day ciclosporin on 3-year incidence of chronic lung allograft dysfunction after lung transplantation in Scandinavia (ScanCLAD): a multicentre randomised controlled trial

https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00293-X/fulltext?dgcid=hubspot_email_conferencealerts_ers23&utm_campaign=conferencealerts&utm_medium=email&_hsmi=273463263&_hsenc=p2ANqtz-_ID52n7ejv3yaFfvXhRDau_w5uautO1FQ3O0fiZDLTFY_YfxJDp-JX9Kx67BThJ3XJSYmRcqIJsgK7kOv2L-G--QYSmw&utm_content=273463263&utm_source=hs_email